Unique experiences
We’re committed to delivering long-term value across our extensive life science network. Through our carefully crafted meetings, collaborative experiences and services Proventa International can offer you the perfect opportunity to meet your business goals, whatever they may be.
Whether you’re seeking answers to the industry’s biggest challenges, investing in new innovations or hoping to identify your next key partnership – Proventa International can help you get there.
What we offer
Unlock the future of life sciences with our exceptional events and transformative services tailored for pharmaceuticals, biotech companies, and service providers. Experience groundbreaking conferences, seminars, and workshops where you’ll access the latest advancements, emerging trends, and visionary strategies shaping the industry.
Strategy Meetings
Join intimate conference events where senior industry leaders tackle the biggest challenges in life sciences. Gain insights, network with pioneers, and be part of groundbreaking advancements.
Overview
Consulting
Ignite growth and unlock untapped potential in the dynamic world of life sciences with our groundbreaking business development consulting service.
Overview
Investment
Unleash the potential of life-changing medicines and meet visionary investors driving impactful change in healthcare. Join us as we pave the way for the next generation of transformative breakthroughs.
OverviewPharmaFeatures provides thought-leading interviews, industry reports and innovative daily content on the newest trends and breaking news across life sciences. In addition to clients within the pharmaceutical space, PharmaFeatures tailors to readers in biotechnology, clinical research, bioinformatics and more.
13th Jan 2026
13th Jan 2026
Open Nucleotides: Grant-Driven Infrastructure for Equitable mRNA Vaccine Manufacturing
By developing accessible cap analogs and RNA raw materials, Hongene Biotech, guided by David Butler’s expertise in nucleotide chemistry and supported by the Gates Foundation, is reshaping the molecular infrastructure that underpins global mRNA vaccine equity.
Full Article
12th Jan 2026
12th Jan 2026
Negotiated Degeneration: How Molecular Intervention and Access Architecture Shape Neurodegenerative Outcomes
Through their partnership, Cycle Pharmaceuticals and Inceptua Group illustrate how operational excellence and access strategy can be as decisive as scientific innovation in rare and degenerative disease therapeutics.
Full Article
08th Jan 2026
08th Jan 2026
Genome to Market: How a Digital–Biological Alliance Reshapes Rare Disease Development
Led by Peter Gassner at Veeva Systems and Alexander Hardy at BioMarin Pharmaceutical Inc., the partnership signals a shared executive vision to fuse technology leadership with rare disease science to deliver transformative medicines to patients worldwide.
Full ArticleHere To Help
Want to know more? Interested in sponsoring the event? Need help registering your team? Just get in touch and a member of the team will be happy to help.
Interested? See for yourself
Take the first step and see where Proventa International can take you. Join one of our unique one-day strategy meetings.




